Madrigal Pharmaceuticals Operating Income 2010-2024 | MDGL
Madrigal Pharmaceuticals operating income for the twelve months ending September 30, 2024 was $-0.548B, a 57.21% increase year-over-year.
- Madrigal Pharmaceuticals annual operating income for 2023 was $-0.38B, a 29.61% increase from 2022.
- Madrigal Pharmaceuticals annual operating income for 2022 was $-0.294B, a 21.07% increase from 2021.
- Madrigal Pharmaceuticals annual operating income for 2021 was $-0.242B, a 17.33% increase from 2020.